The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Cancer associated fibroblasts in cancer pathogenesis
Open accessAbstract
In the past century, gradual but sustained advances in our understanding of the molecular mechanisms involved in the growth and invasive properties of cancer cells have led to better management of tumors. However, many tumors still escape regulation and progress to advanced disease. Until recently, there has not been an organized and sustained focus on the “normal” cells in the vicinity of tumors. Interactions between the tumor and these host cells, as well as autonomous qualities of the host cells themselves, might explain why tumors in people with histologically similar cancers often behave and respond differently to treatment. Cells of the tumor microenvironment, variously referred to as cancer stroma, reactive stroma or carcinoma associated fibroblasts (CAF), exist in close proximity to the cancer epithelium. Both stromal and epithelial phenotypes co-evolve during tumorigenesis and it is now becoming clear that these stromal cells may not be the innocent bystanders they had been widely thought to be, but rather may be active contributors to carcinogenesis. Our group and others have shown the important role that CAF play in the progression of cancer. In this article we will address current trends in the study of the interactions between cancer stroma and tumor cells in different organs. We will also highlight perceived knowledge gaps and suggest research areas that need to be further explored to provide new targets for anti-cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“In cancers, sometimes described as resembling chronic wounds, the origin of myofibroblasts remains controversial; however, their presence may be essential for much invasive growth and is translated into poor clinical prognosis [9].”
BackgroundOrimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Androgen Receptor in Prostate Cancer
Heinlein, C. A., & Chang, C. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0032 · Cited by 1,780
Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium
Olumi, A., Grossfeld, G., Hayward, S., Carroll, P., Cunha, G., Hein, P., & Tlsty, T. (2000) · Breast Cancer Research · doi:10.1186/bcr138 · Cited by 1,463
Self-citationTGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia
Bhowmick, N. A., Chytil, A., Plieth, D., Gorska, A. E., Dumont, N., Shappell, S., Washington, M. K., Neilson, E. G., & Moses, H. L. (2004) · Science · doi:10.1126/science.1090922 · Cited by 1,401
Molecular characterization of the tumor microenvironment in breast cancer
Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.010 · Cited by 1,299
Kolf, C. M., Cho, E., & Tuan, R. S. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2116 · Cited by 1,173
Discovery of Endothelial to Mesenchymal Transition as a Source for Carcinoma-Associated Fibroblasts
Zeisberg, E. M., Potenta, S., Xie, L., Zeisberg, M., & Kalluri, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-3127 · Cited by 1,011
Tissue repair and the dynamics of the extracellular matrix
Midwood, K. S., Williams, L. V., & Schwarzbauer, J. E. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.12.003 · Cited by 919
Studeny, M., Marini, F. C., Dembinski, J. L., Zompetta, C., Cabreira-Hansen, M., Bekele, B. N., Champlin, R. E., & Andreeff, M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh299 · Cited by 842
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Khakoo, A. Y., Pati, S., Anderson, S. A., Reid, W., Elshal, M. F., Rovira, I. I., Nguyen, A. T., Malide, D., Combs, C. A., Hall, G., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051921 · Cited by 747
Stromal myofibroblasts are drivers of invasive cancer growth
De Wever, O., Demetter, P., Mareel, M., & Bracke, M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23925 · Cited by 722
Identification of fibroblast heterogeneity in the tumor microenvironment
Sugimoto, H., Mundel, T. M., Kieran, M. W., & Kalluri, R. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.12.3354 · Cited by 699
Folkman, J., & Kalluri, R. (2004) · Nature · doi:10.1038/427787a · Cited by 519
REACTIVE STROMA IN PROSTATE CANCER PROGRESSION
TUXHORN, J. A., AYALA, G. E., & ROWLEY, D. R. (2001) · Journal of Urology · doi:10.1016/s0022-5347(05)65620-0 · Cited by 502
Kurose, K., Gilley, K., Matsumoto, S., Watson, P. H., Zhou, X.-P., & Eng, C. (2002) · Nature Genetics · doi:10.1038/ng1013 · Cited by 418
Moinfar, F., Man, Y., Arnould, L., Bratthauer, G. L., Ratschek, M., & Tavassoli, F. A. (2000) · PubMed · Cited by 403
MOLECULAR INSIGHTS INTO PROSTATE CANCER PROGRESSION: THE MISSING LINK OF TUMOR MICROENVIRONMENT
CHUNG, L. W. K., BASEMAN, A., ASSIKIS, V., & ZHAU, H. E. (2005) · Journal of Urology · doi:10.1097/01.ju.0000141582.15218.10 · Cited by 361
Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.
Ayala, G., Tuxhorn, J. A., Wheeler, T. M., Frolov, A., Scardino, P. T., Ohori, M., Wheeler, M., Spitler, J., & Rowley, D. R. (2003) · PubMed · Cited by 355
Malignant transformation in a nontumorigenic human prostatic epithelial cell line.
Hayward, S. W., Wang, Y. Z., Cao, M., Hom, Y. K., Zhang, B., Grossfeld, G. D., Sudilovsky, D., & Cunha, G. R. (2001) · PubMed · Cited by 345
Self-citationLöhr, M. J., Schmidt, C., Ringel, J., Kluth, M., Müller, P., Nizze, H., & Jesnowski, R. (2001) · PubMed · Cited by 325
Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis
Hill, R., Song, Y., Cardiff, R. D., & Van Dyke, T. (2005) · Cell · doi:10.1016/j.cell.2005.09.030 · Cited by 324
Tuxhorn, J. A., McAlhany, S. J., Dang, T. D., Ayala, G. E., & Rowley, D. R. (2002) · PubMed · Cited by 283
Qiu, W., Hu, M., Sridhar, A., Opeskin, K., Fox, S., Shipitsin, M., Trivett, M., Thompson, E. R., Ramakrishna, M., Gorringe, K. L., et al. (2008) · Nature Genetics · doi:10.1038/ng.117 · Cited by 282
Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction
Ishii, G., Sangai, T., Oda, T., Aoyagi, Y., Hasebe, T., Kanomata, N., Endoh, Y., Okumura, C., Okuhara, Y., Magae, J., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01544-4 · Cited by 281
Ao, M., Franco, O. E., Park, D., Raman, D., Williams, K., & Hayward, S. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3946 · Cited by 278
Self-citationCheng, N., Bhowmick, N. A., Chytil, A., Gorksa, A. E., Brown, K. A., Muraoka, R., Arteaga, C. L., Neilson, E. G., Hayward, S. W., & Moses, H. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208685 · Cited by 267
Self-citationSuppression of Tumor Development and Metastasis Formation in Mice Lacking the S100A4(mts1) Gene
Grum-Schwensen, B., Klingelhofer, J., Berg, C. H., El-Naaman, C., Grigorian, M., Lukanidin, E., & Ambartsumian, N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4510 · Cited by 235
Henshall, S. M., Quinn, D. I., Lee, C. S., Head, D. R., Golovsky, D., Brenner, P. C., Delprado, W., Stricker, P. D., Grygiel, J. J., & Sutherland, R. L. (2001) · PubMed · Cited by 208
Verras, M., Lee, J., Xue, H., Li, T.-H., Wang, Y., & Sun, Z. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3552 · Cited by 203
Tuxhorn, J. A., McAlhany, S. J., Yang, F., Dang, T. D., & Rowley, D. R. (2002) · PubMed · Cited by 195
Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
Wu, J. D., Haugk, K., Woodke, L., Nelson, P., Coleman, I., & Plymate, S. R. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20929 · Cited by 188
Precise microdissection of human prostate cancers reveals genotypic heterogeneity.
Macintosh, C. A., Stower, M. J., Reid, N., & Maitland, N. J. (1998) · PubMed · Cited by 181
Kunz‐Schughart, L. A., & Knuechel, R. (2002) · PubMed · doi:10.14670/hh-17.599 · Cited by 161
Prostate tumor progression is mediated by a paracrine TGF-β/Wnt3a signaling axis
Li, X., Placencio, V. R., Iturregui, J. M., Uwamariya, C., Sharif‐Afshar, A., Koyama, T., Hayward, S. W., & Bhowmick, N. A. (2008) · Oncogene · doi:10.1038/onc.2008.293 · Cited by 159
Self-citationPancreatic cancer: state-of-the-art care
Lillemoe, K. D., Yeo, C. J., & Cameron, J. L. (2000) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.4.241 · Cited by 156
Wikström, P., Marusic, J., Stattin, P. E., & Bergh, A. R. J. (2009) · The Prostate · doi:10.1002/pros.20927 · Cited by 147
Noël, A., Pauw-Gillet, M. C. D., Purnell, G., Nusgens, B., LAPIERE, C. H. M., & Foidart, J. M. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.453 · Cited by 143
Fukino, K., Shen, L., Matsumoto, S., Morris, Q., Mutter, G. L., & Eng, C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2866 · Cited by 141
Yanagisawa, N., Li, R., Rowley, D. R., Liu, H., Kadmon, D., Miles, B. J., Wheeler, T. M., & Ayala, G. E. (2007) · Human Pathology · doi:10.1016/j.humpath.2007.04.008 · Cited by 138
Emerging roles of chemokines in prostate cancer
Vindrieux, D., Escobar, P., & Lazennec, G. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0109 · Cited by 129
Functions and regulation of transforming growth factor-beta (TGF-β) in the prostate
Danielpour, D. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.027 · Cited by 119
ten Haaf, A., Bektas, N., von Serényi, S., Losen, I., Arweiler, E. C., Hartmann, A., Knüchel, R., & Dahl, E. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-298 · Cited by 119
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A. K., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Cited by 119
Ricciardelli, C., Choong, C. S., Buchanan, G., Vivekanandan, S., Neufing, P. J., Stahl, J., Marshall, V. R., Horsfall, D. J., & Tilley, W. D. (2004) · The Prostate · doi:10.1002/pros.20154 · Cited by 116
Ao, M., Williams, K., Bhowmick, N. A., & Hayward, S. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4451 · Cited by 114
Self-citationLu, T., Burdelya, L. G., Swiatkowski, S. M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402048101 · Cited by 104
Schor, S. L., & Schor, A. M. (1987) · BioEssays · doi:10.1002/bies.950070503 · Cited by 103
Tanaka, H., Nakamura, M., Kameda, C., Kubo, M., Sato, N., Kuroki, S., Tanaka, M., & Katano, M. (2009) · PubMed · Cited by 100
Aoki, H., Ohnishi, H., Hama, K., Shinozaki, S., Kita, H., Yamamoto, H., Osawa, H., Satō, K., Tamada, K., & Sugano, K. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20906 · Cited by 85
Prostate Cancer and the Met Hepatocyte Growth Factor Receptor
Knudsen, B. S., & Edlund, M. (2004) · Advances in cancer research · doi:10.1016/s0065-230x(04)91002-0 · Cited by 82
Watch thy neighbor: cancer is a communal affair
Weaver, V. M., & Gilbert, P. M. (2004) · Journal of Cell Science · doi:10.1242/jcs.01137 · Cited by 82
Tumor‐promoting phenotype of CD90hi prostate cancer‐associated fibroblasts
Zhao, H., & Peehl, D. M. (2009) · The Prostate · doi:10.1002/pros.20946 · Cited by 78
Sadlonova, A., Bowe, D. B., Novák, Z., Mukherjee, S., Duncan, V. E., Page, G. P., & Frost, A. R. (2009) · Cancer Microenvironment · doi:10.1007/s12307-008-0017-0 · Cited by 73
Cheng, N., Chytil, A., Shyr, Y., Joly, A. H., & Moses, H. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3381 · Cited by 73
In vivo disruption of TGF-β signaling by Smad7 leads to premalignant ductal lesions in the pancreas
Kuang, C., Xiao, Y., Liu, X., Stringfield, T. M., Zhang, S., Wang, Z., & Chen, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508977103 · Cited by 63
Role of IGF-1/IGF-1R in regulation of invasion in DU145 prostate cancer cells
Saikali, Z., Setya, H. C., Singh, G., et al. (2008) · Cancer Cell International · doi:10.1186/1475-2867-8-10 · Cited by 56
Grover, A. C., Tangrea, M. A., Woodson, K. G., et al. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-13 · Cited by 39
HGF/SF up-regulates the expression of bone morphogenetic protein 7 in prostate cancer cells
Ye, L., Lewis-Russell, J. M., Sanders, A. J., Kynaston, H., & Jiang, W. G. (2007) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.03.027 · Cited by 23
Cited by
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
Tumor angiogenesis: molecular pathways and therapeutic targets
Weis, S. M., & Cheresh, D. A. (2011) · Nature Medicine · doi:10.1038/nm.2537 · Cited by 1,736
Bremnes, R. M., Dønnem, T., Al-Saad, S., Al-Shibli, K., Andersen, S., Sirera, R., Camps, C., Marinez, I., & Busund, L.-T. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181f8a1bd · Cited by 691
Chen, F., Chandrashekar, D. S., Varambally, S., & Creighton, C. J. (2019) · Nature Communications · doi:10.1038/s41467-019-13528-0 · Cited by 529
Classifying the evolutionary and ecological features of neoplasms
Maley, C. C., Aktipis, A., Graham, T. A., Sottoriva, A., Boddy, A. M., Janiszewska, M., Silva, A. S., Gerlinger, M., Yuan, Y., Pienta, K. J., et al. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.69 · Cited by 423
Metadata
- Authors
- Franco, O. E., Shaw, A. K., Strand, D. W., & Hayward, S. W.
- Venue
- Seminars in Cell & Developmental Biology
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 21
- Issue
- 1
- Pages
- 33-39
- ISSN
- 1084-9521 (ISSN-L)
- OpenAlex
- W2029712941
- Cited by
- 394
- References
- 63
- FWCI
- 8.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.